Live tape
Top 8, mentions 7d9,972TSLA2,035 mentions▲ +0.05GOOGL1,647 mentions▲ +0.05NVDA1,247 mentions▲ +0.07CRWV1,120 mentions▲ +0.03SPCX1,084 mentions▲ +0.07QQQ1,056 mentions▲ +0.04META906 mentions▲ +0.05MSFT877 mentions▲ +0.05

Equity · Healthcare

CPRX

NASDAQ

Catalyst Pharmaceuticals, Inc.

$31.49 −0.06% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close)
Price · Chart

This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for CPRX to draw a line in its place.

Track this symbol on TradingView TradingView chart
Market cap $3.9B
P/E (TTM) 17.7
52-week range $19.12 – $31.51
Avg volume 367.4K

as of Jul 14, 2026

CPRX insider trades

SEC Form 4

CPRX has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 15 July 2026.

Date Insider Type Shares Value
12 Dec 2025 Harper Molly Sell 26,746 $622K
26 Nov 2025 Del Carmen Jeffrey Chief Commercial Officer Sell 10,983 $256K
12 Nov 2025 Elsbernd Brian Chief Compliance/Legal Officer Sell 40,000 $908K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
15 Jul 2026 Andrews William T. Chief Medical Officer Other 2,309 $73K
15 Jul 2026 Daly Richard J President and CEO Other 271,266 $8.54M
15 Jul 2026 Del Carmen Jeffrey Chief Commercial Officer Other 14,337 $452K
15 Jul 2026 DENKHAUS DONALD A Director Other 498,773 $15.71M
15 Jul 2026 Elsbernd Brian Chief Legal Officer Other 242,501 $7.64M
15 Jul 2026 Harper Molly Director Other 3,694 $116K
15 Jul 2026 Kalb Michael Wayne Chief Financial Officer Other 13,665 $430K
15 Jul 2026 MCENANY PATRICK J Director Other 4,171,559 $131.40M
15 Jul 2026 Miller Steve Chief Op. & Scientific Officer Other 1,093,803 $34.45M
15 Jul 2026 Russo Gregg Chief HR Officer Other 476 $15K
15 Jul 2026 Sundaram Preethi Chief Strategy Officer Other 54,804 $1.73M
15 Jul 2026 Thompson Tamar Director Other 3,773 $119K

Showing the 12 most recent of 80 compensation filings in this window. The figures above count all of them.

CPRX reported financials

SEC EDGAR XBRL SEC EDGAR

CPRX reported revenue of $589.0M for the fiscal year ended 31 Dec 2025. Net income over the same period was $214.3M.

Figure Reported Period
Revenue $589.0M 31 Dec 2025 fiscal year
Net income $214.3M 31 Dec 2025 fiscal year
Diluted EPS $1.68 31 Dec 2025 fiscal year
Total assets $1.1B 31 Mar 2026 at period end
Total equity $1.0B 31 Mar 2026 at period end

CPRX earnings

SEC EDGAR
Date Period EPS Revenue
31 Mar 2026 Q1 2026 $0.50 —
31 Dec 2025 FY 2025 $1.68 —
30 Sep 2025 Q3 2025 $0.42 —
30 Jun 2025 Q2 2025 $0.41 —
31 Mar 2025 Q1 2025 $0.45 —
31 Dec 2024 FY 2024 $1.31 —
30 Sep 2024 Q3 2024 $0.35 —
30 Jun 2024 Q2 2024 $0.33 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

CPRX institutional holders

SEC Form 13F SEC EDGAR

11 of the 45 institutional funds we track reported a CPRX position for the quarter ended 30 Jun 2026 — a combined $163.7M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Renaissance Technologies Held (±25%) −9.0% shares 2,136,077 $67.1M
Millennium Management Added +39.3% shares 1,068,724 $33.6M
Marshall Wace Added +351.8% shares 911,700 $28.7M
Soros Fund Management New position 344,593 $10.8M
Man Group Added +191.2% shares 250,000 $7.9M
Point72 Asset Management Trimmed −58.5% shares 176,560 $5.5M
D. E. Shaw & Co. Added +231.8% shares 134,531 $4.2M
Citadel Advisors Trimmed −85.3% shares 85,147 $2.7M
AQR Capital Management Trimmed −75.2% shares 56,597 $1.8M
Two Sigma Investments New position 30,354 $954K

Showing the 10 largest of 11 reported positions. The figures above count all of them.

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close)
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 31 Mar 2026
  4. SEC EDGARSEC EDGAR 13F filings
  5. SEC EDGARValuation computed from SEC EDGAR filings